本页面由Tiger Trade Technology Pte. Ltd.提供服务

Principia Biopharma Inc.

100.05
0.0000
成交量:- -
成交额:- -
市值:33.28亿
市盈率:-44.01
高:100.05
开:100.05
低:100.05
收:100.05
52周最高:101.89
52周最低:25.35
股本:3,325.99万
流通股本:2,304.04万
量比:- -
换手率:- -
股息:- -
股息率:- -
每股收益(TTM):-2.2732
每股收益(LYR):-2.0867
净资产收益率:-26.40%
总资产收益率:-16.03%
市净率:9.47
市盈率(LYR):-47.95

数据加载中...

2021/02/16

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/10/01

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/28

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2020/09/28

交易所摘牌声明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2020/09/28

重要事件披露

8-K - Current report
2020/09/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/08/25

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/08/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/08/17

重要事件披露

8-K - Current report
2020/08/06

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/06

重要事件披露

8-K - Current report
2020/06/26

重要事件披露

8-K - Current report
2020/06/12

重要事件披露

8-K - Current report
2020/06/09

重要事件披露

8-K - Current report
2020/05/06

季度报告

Quarterly report [Sections 13 or 15(d)]
2020/05/06

重要事件披露

Current report, items 2.02 and 9.01
2020/04/24

重要事件披露

Current report, item 8.01
2020/03/10

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans